The semi-solid capabilities at Kemwell, like the oral solids capability, are available at both the Bangalore, India campus, as well as our Uppsala, Sweden site. Current capacity is 75 million units annually, with capabilities to handle:
- Ointments (sterile/non-sterile)
- Topical Powders
Kemwell manufactures products used for anti-fungal/anti-bacterial (including female health products), antibiotics, muscle-relaxant, and sting-rash applications. The unit also produces eye ointments, which are terminally sterilized.